V-Square Quantitative Management’s ResMed RMD Stock Holding History

V-Square Quantitative Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Buy	1,995 +592	+42%	+$123K	0.04%	388
2026 Q1	$315K	Buy	1,403 +100	+8%	+$24.9K	0.03%	420
2025 Q4	$314K	Buy	+1,303	New	+$333K	0.03%	417
2025 Q3	–	Sell	-1,747	Closed	-$451K	–	500
2025 Q2	$451K	Buy	1,747 +51	+3%	+$12.2K	0.06%	320
2025 Q1	$380K	Buy	1,696 +10	+0.6%	+$2.33K	0.06%	363
2024 Q4	$386K	Sell	1,686 -33	-2%	-$7.95K	0.05%	361
2024 Q3	$420K	Buy	1,719 +171	+11%	+$38.2K	0.06%	344
2024 Q2	$296K	Sell	1,548 -335	-18%	-$68K	0.05%	366
2024 Q1	$373K	Buy	1,883 +575	+44%	+$105K	0.05%	330
2023 Q4	$225K	Hold	1,308	–	–	0.04%	396
2023 Q3	$193K	Buy	+1,308	New	+$237K	0.09%	363
2023 Q2	–	Sell	-915	Closed	-$200K	–	478
2023 Q1	$200K	Buy	+915	New	+$199K	0.18%	139

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

V-Square Quantitative Management's RMD Position: Q2 2026 in Review

V-Square Quantitative Management increased its ResMed (RMD) stake by 42% in Q2 2026, buying an estimated $123K and bringing the position to 1,995 shares worth $389K. The position accounts for 0.04% of the portfolio, ranked #388.

V-Square Quantitative Management first reported a position in RMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $451K in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

V-Square Quantitative Management held 1,995 shares of ResMed worth $389K as of Q2 2026.
V-Square Quantitative Management bought 592 ResMed shares in Q2 2026, an estimated $123K.
ResMed made up 0.04% of V-Square Quantitative Management's portfolio in Q2 2026, its #388 holding.
V-Square Quantitative Management first reported a position in ResMed in Q1 2023 and has held it in 12 quarters since.
V-Square Quantitative Management's ResMed position peaked at $451K in Q2 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.